VZ Insider Filing: Kyle Malady Reports Deferred-Comp Phantom Stock Acquisition
Rhea-AI Filing Summary
Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications (VZ), reported a non-derivative/derivative-equivalent transaction on 08/14/2025 under a Form 4. The filing shows acquisition of 139.437 units of phantom stock (unitized), each unit being the economic equivalent of a portion of one share of common stock and settled in cash. The filing records an associated line showing 40 shares of common stock at $12.41 and total beneficial ownership following the transaction of 388,442.851 units held indirectly through a deferred compensation plan. Footnotes state phantom units become payable per the reporting person’s elections under the deferred compensation plan and include units acquired through dividend reinvestment.
Positive
- Transaction disclosed under Section 16, satisfying insider reporting requirements
- Use of deferred compensation plan indicates the acquisition is compensation-related and cash-settled, not an open-market sale
Negative
- No open-market purchase or sale data provided to indicate trading interest by the reporting person
- Filing does not clarify the $12.41 figure’s exact context beyond the table line shown
Insights
TL;DR: Routine deferred-compensation settlement reported by an executive; no open-market purchase or sale disclosed.
The Form 4 documents an internal acquisition of phantom stock under Verizon’s deferred compensation plan rather than an open-market trade. The filing explicitly states the units are cash-settled and payable per the executive’s plan elections, and that dividend reinvestment contributed to the reported balance. From a governance perspective, this is a routine disclosure of executive compensation deferral and does not indicate a change in control or a transaction involving company equity being transferred on public markets.
TL;DR: Transaction is compensation-related and recorded as indirect beneficial ownership; it appears non-material to company capitalization.
The Form 4 records acquisition of 139.437 phantom stock units and shows a large indirect holding of 388,442.851 units via the deferred compensation plan. The disclosure includes a $12.41 figure associated with a 40-share line item and notes dividend reinvestment. There is no explicit cash purchase or sale on the open market, no exercise of equity awards for actual share issuance, and no change to outstanding common stock cited in this filing. Impact on share count or liquidity is not indicated in the document.